Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-19-005387

CEO and President bought 8,000 shares at an average $3.87 ($30,987)

From the SEC's structured data for this filing

Trades in this filing

Kendall Keith J · CEO and President

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-09 Purchase : show line 1 in the form +2,000 $3.84 $7,680 648,581 D
2019-08-09 Purchase : show line 2 in the form +1,000 $3.93 $3,925 649,581 D
2019-08-09 Purchase : show line 3 in the form +2,000 $4.00 $7,990 651,581 D
2019-08-13 Purchase : show line 4 in the form +1,000 $4.05 $4,045 652,581 D
2019-08-14 Purchase : show line 5 in the form +1,000 $3.70 $3,697 653,581 D
2019-08-14 Purchase : show line 6 in the form +1,000 $3.65 $3,650 654,581 D
Open-market purchases · 8,000 sh · avg $3.87 · $30,987
Loading xslF345X03/marketforms-45524.xml…